Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
LPL Financial Holdings Inc. · LPLA · FY2025 Q4 · Calendar Q1 2026
LPL's Q4 results support a constructive operating picture: organic asset growth and record adjusted EPS coincided with improving operating leverage. The durability of that growth depends on Commonwealth integration and retention, recruiting conversion, and the effect of rate changes on cash-sweep economics.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Compared with Q3 2025, management's analysis points to total assets rising from $2.3 trillion to a record $2.4 trillion and adjusted EPS increasing from $5.20 to $5.23. The Q4 analysis also highlights 8% year-over-year organic asset growth, while Commonwealth integration and its expected EBITDA contribution remain central to the outlook.
Guidance sentiment was characterized as maintained. The supplied analysis identifies no guidance reset; management expects a $425 million run-rate EBITDA contribution from Commonwealth once integrated, while buybacks remain paused pending the leverage target.
Follow LPLA with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 free1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 2, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Oct 29, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 28, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 28, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 28, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 28, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 28, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 9, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 6, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Oct 5, 2026 |
| B of A Securities | Buy | Buy | Maintain | Oct 5, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Jul 31, 2026 |
| Keefe Bruyette | Outperform | Outperform | Maintain | Apr 8, 2026 |
| Raymond James | Underperform | Upgrade | Oct 9, 2025 | |
| Rothschild & Co Redburn | Neutral | Buy | Downgrade | Sep 19, 2025 |
| Citigroup | Sell | Neutral | Downgrade | Jul 9, 2025 |
| Redburn Atlantic | Buy | Neutral | Upgrade | Jun 9, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 9, 2024 |
| Jefferies | Buy | Buy | Maintain | Oct 4, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Sep 26, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 28, 2023 |
| Compass Point | Neutral | Buy | Downgrade | May 8, 2019 |
| Bernstein | Outperform | Outperform | Maintain | Apr 10, 2018 |
| Nomura | Buy | Buy | Maintain | Feb 2, 2018 |
| Keefe Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 29, 2016 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Jun 2, 2016 |
| Susquehanna | Neutral | Negative | Upgrade | Feb 5, 2016 |
| S&P Capital IQ | Hold | Buy | Downgrade | Jan 2, 2014 |
| Bank of America | Neutral | Neutral | Maintain | Feb 21, 2012 |
Upside is calculated against the persisted current price $283.74. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | Alexander Blostein | $400 | $317.56 | +41.0% | Oct 28, 2026 |
| Truist Financial | Analyst unavailable | $354 | $323.67 | +24.8% | Oct 13, 2026 |
| Morgan Stanley | Analyst unavailable | $393 | $328 | +38.5% | Oct 9, 2026 |
| Barclays | Analyst unavailable | $409 | $332.39 | +44.1% | Oct 7, 2026 |
| UBS | Analyst unavailable | $390 | $332.39 | +37.4% | Oct 7, 2026 |
| Capital One Financial | Analyst unavailable | $370 | $335.59 | +30.4% | Oct 6, 2026 |
| Oppenheimer | Analyst unavailable | $554 | $316.44 | +95.2% | Oct 5, 2026 |
| Wells Fargo | Daniel Welden | $362 | $312.15 | +27.6% | Oct 1, 2026 |
| Truist Financial | David Smith | $389 | $370.14 | +37.1% | Sep 1, 2026 |
| Wolfe Research | Analyst unavailable | $454 | $371.19 | +60.0% | Aug 12, 2026 |
| BMO Capital | Analyst unavailable | $390 | $353.7 | +37.4% | Aug 3, 2026 |
| Barclays | Analyst unavailable | $401 | $339.17 | +41.3% | Jul 31, 2026 |
| Morgan Stanley | Analyst unavailable | $387 | $314.31 | +36.4% | Jul 10, 2026 |
| Barclays | Analyst unavailable | $394 | $311.41 | +38.9% | Jul 9, 2026 |
| Barclays | Analyst unavailable | $412 | $334.13 | +45.2% | May 1, 2026 |
| Morgan Stanley | Michael Cyprys | $374 | $307.94 | +31.8% | Apr 10, 2026 |
| UBS | Analyst unavailable | $500 | $376.33 | +76.2% | Feb 3, 2026 |
| Wolfe Research | Analyst unavailable | $478 | $362.28 | +68.5% | Jan 30, 2026 |
| Barclays | Benjamin Budish | $434 | $362.71 | +53.0% | Jan 30, 2026 |
| Barclays | Analyst unavailable | $444 | $359.38 | +56.5% | Jan 8, 2026 |
| Wolfe Research | Analyst unavailable | $486 | $365.74 | +71.3% | Jan 7, 2026 |
| Morgan Stanley | Analyst unavailable | $447 | $362.46 | +57.5% | Dec 22, 2025 |
| Barclays | Analyst unavailable | $453 | $387.5 | +59.7% | Dec 12, 2025 |
| UBS | Michael Brown | $406 | $386.99 | +43.1% | Dec 11, 2025 |
| JMP Securities | Analyst unavailable | $475 | $338.49 | +67.4% | Oct 31, 2025 |
| Barclays | Analyst unavailable | $420 | $338.49 | +48.0% | Oct 31, 2025 |
| Goldman Sachs | Alexander Blostein | $421 | $338.49 | +48.4% | Oct 31, 2025 |
| UBS | Analyst unavailable | $455 | $325.13 | +60.4% | Oct 9, 2025 |
| Barclays | Benjamin Budish | $411 | $317.32 | +44.9% | Oct 8, 2025 |
| Morgan Stanley | Analyst unavailable | $462 | $323.33 | +62.8% | Oct 1, 2025 |
| Barclays | Analyst unavailable | $460 | $362.83 | +62.1% | Sep 2, 2025 |
| Barclays | Benjamin Budish | $379 | $335.64 | +33.6% | Jan 13, 2025 |
| Wells Fargo | Michael Brown | $285 | $245.83 | +0.4% | Oct 9, 2024 |
| Goldman Sachs | Alexander Blostein | $271 | $230.35 | -4.5% | Sep 25, 2024 |
| Bank of America Securities | Craig Siegenthaler | $268 | $221.58 | -5.5% | Jul 30, 2024 |
| JMP Securities | Devin Ryan | $310 | $239.2 | +9.3% | Jul 26, 2024 |
| Barclays | Benjamin Budish | $273 | $239.2 | -3.8% | Jul 26, 2024 |
| Barclays | Benjamin Budish | $313 | $273.22 | +10.3% | Jul 10, 2024 |
| Jefferies | Gerald O'Hara | $334 | $272.66 | +17.7% | Jul 8, 2024 |
| Barclays | Benjamin Budish | $319 | $269.13 | +12.4% | May 1, 2024 |
| JMP Securities | Devin Ryan | $305 | $261.3 | +7.5% | Apr 9, 2024 |
| Morgan Stanley | Michael Cyprys | $315 | $261.3 | +11.0% | Apr 9, 2024 |
| UBS | Analyst unavailable | $250 | $216.94 | -11.9% | Aug 4, 2022 |
| Morgan Stanley | Analyst unavailable | $246 | $191.25 | -13.3% | Apr 29, 2022 |
| Compass Point | Christopher Allen | $195 | $163.51 | -31.3% | Oct 29, 2021 |
| Wells Fargo | Christopher Harris | $174 | $155.69 | -38.7% | Apr 30, 2021 |
| Barclays | Jeremy Campbell | $175 | $155.69 | -38.3% | Apr 30, 2021 |
Track every rating change on LPLA the moment it posts. Free to start.
Start freeLPL Financial Holdings Inc., operating through its subsidiaries, delivers an integrated ecosystem of brokerage and investment advisory solutions. These services are primarily aimed at independent financial professionals and advisors affiliated with financial institutions across the United States. The firm's brokerage division offers a diverse range of financial instruments, encompassing various annuities (both variable and fixed), mutual funds, equities, and savings vehicles for retirement and education. It also includes fixed income products, insurance, and specialized alternative investments such as non-traded real estate investment trusts and auction rate notes.…
| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CBOE Cboe Global Markets, Inc. | FY2026 Q3 · Calendar Q4 2026 | +5.8% | +6.8% | Cboe posts strong Q3 as options growth and new products advance |
| NWG NatWest Group plc | FY2026 Q3 · Calendar Q4 2026 | +2.0% | -9.0% | NatWest maintains guidance as Q3 growth and capital remain strong |
| ERIE Erie Indemnity Company | FY2026 Q3 · Calendar Q4 2026 | +2.1% | +5.3% | Erie pairs resilient demand initiatives with thin underwriting margins |
| COIN Coinbase Global, Inc. | FY2026 Q3 · Calendar Q4 2026 | +1189.2% | -10.6% | Coinbase offsets lower spot trading with prediction markets and AI agents |
| TPG TPG Inc. | FY2026 Q3 · Calendar Q4 2026 | +4.3% | +7.5% | TPG raises FRE margin outlook as capital formation accelerates |
| AJG Arthur J. Gallagher & Co. | FY2026 Q3 · Calendar Q4 2026 | +0.3% | +2.9% | AJG: Q3 growth and AssuredPartners synergies support outlook |
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-02. For educational purposes only; not investment advice.